Protagonist Therapeutics, Inc (PTGX) › Capital ExpendituresProtagonist Therapeutics, Inc (PTGX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $299.0K2015: $399.0K2016: $347.0K2017: $666.0K2018: $486.0K2019: $967.0K2020: $471.0K2021: $1.10M2022: $795.0K2023: $609.0K2024: $1.35M2025: $1.59M$1.59M2014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$1.59M+17.3%2024$1.35M+122.5%2023$609.0K-23.4%2022$795.0K-27.8%2021$1.10M+133.8%2020$471.0K-51.3%2019$967.0K+99.0%2018$486.0K-27.0%2017$666.0K+91.9%2016$347.0K-13.0%2015$399.0K+33.4%2014$299.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share